GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » EV-to-EBIT

Cytori Cell Research Institute (TSE:3750) EV-to-EBIT : -10.71 (As of Sep. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cytori Cell Research Institute's Enterprise Value is 円9,183 Mil. Cytori Cell Research Institute's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was 円-857 Mil. Therefore, Cytori Cell Research Institute's EV-to-EBIT for today is -10.71.

The historical rank and industry rank for Cytori Cell Research Institute's EV-to-EBIT or its related term are showing as below:

TSE:3750' s EV-to-EBIT Range Over the Past 10 Years
Min: -7325.49   Med: -1.86   Max: 696.51
Current: -10.7

During the past 13 years, the highest EV-to-EBIT of Cytori Cell Research Institute was 696.51. The lowest was -7325.49. And the median was -1.86.

TSE:3750's EV-to-EBIT is ranked worse than
100% of 440 companies
in the Biotechnology industry
Industry Median: 8.91 vs TSE:3750: -10.70

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cytori Cell Research Institute's Enterprise Value for the quarter that ended in Mar. 2024 was 円10,099 Mil. Cytori Cell Research Institute's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was 円-857 Mil. Cytori Cell Research Institute's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -8.49%.


Cytori Cell Research Institute EV-to-EBIT Historical Data

The historical data trend for Cytori Cell Research Institute's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute EV-to-EBIT Chart

Cytori Cell Research Institute Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.55 -35.14 673.74 -16.88 -11.78

Cytori Cell Research Institute Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.88 -18.62 -20.33 -20.66 -11.78

Competitive Comparison of Cytori Cell Research Institute's EV-to-EBIT

For the Biotechnology subindustry, Cytori Cell Research Institute's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytori Cell Research Institute's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytori Cell Research Institute's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cytori Cell Research Institute's EV-to-EBIT falls into.



Cytori Cell Research Institute EV-to-EBIT Calculation

Cytori Cell Research Institute's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=9183.274/-857.402
=-10.71

Cytori Cell Research Institute's current Enterprise Value is 円9,183 Mil.
Cytori Cell Research Institute's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-857 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytori Cell Research Institute  (TSE:3750) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cytori Cell Research Institute's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-857.402/10098.7499
=-8.49 %

Cytori Cell Research Institute's Enterprise Value for the quarter that ended in Mar. 2024 was 円10,099 Mil.
Cytori Cell Research Institute's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-857 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytori Cell Research Institute EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute Headlines

No Headlines